Navigation Links
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
Date:1/29/2013

uent, Inc.(b) Adjustment to facility-related charges of $0.4 million related to restructuring plan(c) Gain on facility sale previously impaired(d) Tax associated with items (a) through (c), a tax expense for one-time adjustments to deferred tax assets in Q1 FY13,  and a net $2.7 million expense due to changes in interest, penalties and a valuation allowance in a foreign jurisdiction in Q2 FY13
(e) Restructuring charges include $2.5 million in severance costs (net of a $1.0 million reduction in the FY10 Plan) and $1.4 million of facility-related costs and the associated tax impact
PAREXEL International CorporationSegment InformationUnauditedThree Months EndedThree Months Ended(in thousands)12/31/201212/31/2011Clinical Research Services (CRS)Service revenue $
320,580$
247,871% of total service revenue76.0%74.4%Gross profit$
78,165$
70,030Gross margin % of service revenue24.4%28.3%PAREXEL Consulting & Medical   Communications Services (PCMS)Service revenue$
49,274$
38,455% of total service revenue11.7%11.5%Gross profit$
20,820$
5,871Gross margin % of service revenue42.3%41.3%Perceptive Informatics (PI)Service revenue$
52,214$
46,844% of total service revenue12.3%14.1%Gross profit$
21,758$
9,170Gross margin % of service revenue41.7%40.9%Total service revenue$
422,068$
333,170Total gross profit$
20,743$
5,071Gross margin % of service revenue28.6%31.5%Revenue by Geography (a)The Americas$
210,066$
38,215Europe, Middle East & Africa150,108144,832Asia/Pacific61,89450,123Total service revenue$
422,068$
333,170Quarterly Supplemental Financial DataService revenue$
422,068$
333,170Reimbursement revenue61,06954,641Investigator fees96,30754,609Gross revenue$
579,444$
442,420Days sales outstanding4157Capital expen
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
3. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
4. PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening
5. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
6. PAREXEL International To Present At NASDAQ OMX Investor Conference
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
8. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
11. PAREXEL International to Present at Robert Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... PharmaTech (Cayman) Inc. (NYSE: WX ), a leading ... in China and the ... financial results for the second quarter of 2014 after the ... (which will be Thursday morning, August 14, 2014 Shanghai time). ... section of the Company,s website at http://www.wuxiapptec.com . ...
(Date:7/22/2014)... SOUTH EASTON, Mass. , July 22, ... ("PBI" or the "Company") and Parabase Genomics ... have entered into a strategic research and ... of the collaboration, PBI will develop a ... neonatal molecular diagnostics and newborn confirmatory testing ...
(Date:7/22/2014)... , July 22, 2014 ... umfassenden Schutz von Pharmazeuten und Krankenpflegern ... Equashield ( http://www.equashield.com ), ... System Transfer Devices, CSTDs) für gefährliche Medikamente, ernannte ... und Hersteller von medizinischen Produkten, zu seinem ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 3Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 4Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... Cheyenne Regional Medical Center is expanding its ... an AirLife Denver medical helicopter service in ... Regional and HCA-HealthONE, which operates AIRLIFE Denver. ... blue and sonic green helicopter will be stationed in ...
... Systems, Inc. (Nasdaq: DCTH ) announced today that ... Lazard Capital Markets, Eighth Annual Healthcare Conference on Tuesday, November ...  Mr. Hobbs will provide an overview of the Company,s business ... this conference is by invitation only.  Delcath will offer a ...
Cached Medicine Technology:Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 3Delcath to Present at the Lazard Healthcare Conference on November 15 2Delcath to Present at the Lazard Healthcare Conference on November 15 3
(Date:7/22/2014)... American Society of Hematology (ASH) will honor Michael DeBaun, ... Robert P. Hebbel, MD, of the University of Minnesota ... Prize for their significant research advances in the area ... named for the late Ernest Beutler, MD, a past ... years, is a two-part lectureship that recognizes major translational ...
(Date:7/22/2014)... Society of Hematology (ASH) will present the Society,s highest ... Achievement in Hematology, to Kanti R. Rai, MD, of ... Medicine for his 50-year career combining landmark clinical leukemia ... patient care. , The Wallace H. Coulter Award ... individual who has been a vital contributor to the ...
(Date:7/22/2014)... New guidelines on cholesterol treatment and cardiovascular risk assessment ... of dying from atherosclerotic cardiovascular disease or of having ... a similar risk profile (based on age, smoking history, ... this finding for when and how aggressively to treat ... Journal of Men,s Health , a peer-reviewed publication from ...
(Date:7/22/2014)... Los Angeles, CA (PRWEB) July 22, 2014 ... leads the way in providing resources, educational tools and ... that tell the stories of prevention, treatment and recovery. ... drama BLACK BOX will spotlight some of these resources ... Mental Health Services Administration helpline and treatment website at ...
(Date:7/22/2014)... 2014 (HealthDay News) --,High school lacrosse players are facing ... as games, a new study finds. Although the ... 22 percent are concussions, researchers report. They note a ... lead to better ways to protect student athletes. ... underscores the need to learn more about these injuries," ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 3
... Del., Jan. 8 DuPont (NYSE: DD ... Protection,Agency for Agility(TM) SG herbicide, a new product ... for broad spectrum weed control, including,ALS resistant species. ... of action in a single formulation to offer,convenient, ...
... spending slowed for first time since its inception in ... new Medicare prescription drug plan was largely responsible for ... which was double the increase in spending from the ... Medicare spending reached $401.3 billion, an increase from $338 ...
... found that Medicare spending across the country varies greatly. But ... the same no matter which region a person lives in. ... is no value to the excess costs in high-spending areas. ... as a model suggests this is not correct. While ...
... promoting innovation and fuelled by the brain gain of ... biotech industry only needs a more favourable investment climate ... of therapies and medicines both new and low-cost ... Long considered a skillful product replicator, China today boasts ...
... announced today,that it has entered into an agreement with ... product. Breckenridge expects to file an,ANDA with the FDA ... AG will,supply and Breckenridge will market and distribute the ... agreement, Breckenridge will submit an ANDA to the,U.S. Food ...
... a colonoscopy can play a life-saving role by encouraging ... cancer screenings, according to new research from the University ... provide important information to combat myths and fears that ... their doctors often fail to address. In a randomized ...
Cached Medicine News:Health News:New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs 2Health News:Medicare Drug Plan Fuels Health-Care Spending 2Health News:Medicare Drug Plan Fuels Health-Care Spending 3Health News:Higher Medicare spending yields mixed bag for patients 2Health News:Higher Medicare spending yields mixed bag for patients 3Health News:China's biotech industry: An Asian dragon is growing 2Health News:China's biotech industry: An Asian dragon is growing 3Health News:China's biotech industry: An Asian dragon is growing 4Health News:China's biotech industry: An Asian dragon is growing 5Health News:China's biotech industry: An Asian dragon is growing 6Health News:China's biotech industry: An Asian dragon is growing 7Health News:Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany) 2Health News:Colonoscopy fears overcome when patients support patients 2Health News:Colonoscopy fears overcome when patients support patients 3
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
... with a 25-microplate capacity ... and aspiration and dispense ... On-board software for user ... programs. External vacuum pump ...
... microplate washers available to handle ... cell-based assays. Embla 384 Cell ... have been optimized to avoid ... robotic compatible and have been ...
ELISA Microplate Washer, Manual...
Medicine Products: